Central Serous Chorioretinopathy: Etiology, Course and Prognosis
- Conditions
- Central Serous Chorioretinopathy
- Registration Number
- NCT01378130
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.
- Detailed Description
Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Signed informed consent form
- Age over 18 years
- acute episode of Central Serous Chorioretinopathy
- Symptoms for less than two weeks
- no treatment on study eye
- bad compliance
- protected patient group (pregnant women)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Outcome 2 years OCT, Visus
- Secondary Outcome Measures
Name Time Method Subclinical Data 2 years FA findings, retinal sensitivity in Microperimetry, contrast sensitivity, Amsler Grid Test
Trial Locations
- Locations (1)
Vienna Gerenal Hospital
🇦🇹Vienna, Austria